ADAR1 Capital Management »

ACADIA Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.2k 500 18.49

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
D. E. Shaw & Co
Fred Alger Management
Geode Capital Management
Palo Alto Investors
Morgan Stanley
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Tang Capital Management
Susquehanna International

View all funds holding ACADIA Pharmaceuticals